Evaluation of the Efficacy of Tocilizumab in Cytokine Release Syndrome in Patients with COVID-19 (SARS-CoV-2) Pneumonia Followed in the Intensive Care Unit

Objective: The global severe acute respiratory syndrome-coronavirus-2 pandemic, which emerged in 2019, has resulted in severe complications in approximately 5% of infected individuals, leading to mortality due to respiratory failure, shock, or multiple organ dysfunction. Mortality is primarily attri...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Serpil Şehirlioğlu, Fatma Özdemir, Melike Tezdönen, Ülkü Aygen Türkmen, Döndü Genç Moralar
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Istanbul Bagcilar Training and Research Hospital 2025-09-01
coleção:	Bagcilar Medical Bulletin
Assuntos:	covid-19 pneumonia cytokine release syndrome cytokine storm sars-cov-2 tocilizumab
Acesso em linha:	https://www.behmedicalbulletin.org/articles/evaluation-of-the-efficacy-of-tocilizumab-in-cytokine-release-syndrome-in-patients-with-covid-19-sars-cov-2-pneumonia-followed-in-the-intensive-care-unit/doi/BMB.galenos.2025.92400
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!